
Stock Trend Analysis Report
Prepared for you on Friday, March 24, 2023.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Strong Uptrend (+100) - VRTX is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, VRTX continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid VRTX?
MarketClub looks at technical strength and momentum to determine if the timing is right for VRTX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
![]() |
|||||||||||||||
|
MarketClub’s Trade Triangles for VRTX
The long-term trend has been UP since Jan 31st, 2023 at 324.75
The intermediate-term trend has been UP since Mar 13th, 2023 at 296.66
The short-term trend has been UP since Mar 10th, 2023 at 291.85
Smart Scan Analysis for VRTX
Based on our trend formula, VRTX is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Open | High | Low | Price | Change |
---|---|---|---|---|
301.950 | 305.470 | 300.675 | 305.290 | +7.420 |
Prev. Close | Volume | Bid | Ask | Time |
304.750 | 1017561 | 2023-03-23 15:59:50 |
Year High | 194.92 | Year High Date | 2018-10-01 |
Year Low | 144.07 | Year Low Date | 2018-06-06 |
52wk High | 325.19 | 52wk High Date | 2023-01-31 |
52wk Low | 233.01 | 52wk Low Date | 2022-05-11 |
Year End Close | 41.9 | Average Volume | 1,076,103 |
Shares Outstanding | 257,091 | Short Interest | 5,103,343 |
% Institutional | 91.7 | Market Cap | 44,495M |
Assets | 181,509,000M | Liabilities | 423,820,000M |
P/E Ratio | 23.7715 | Beta | 0.2 |
Volatility | 41.6 |